Hendrix Katharine H, Riehle Jessica E, Egan Brent M
College of Health Professions , Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Ethn Dis. 2005 Winter;15(1):11-6.
Demographic differences in management of concomitant lipid disorders among hypertensive patients may contribute to health disparities.
Assess demographic differences in lipid control rates and treatment patterns among dyslipidemic hypertensive patients in primary care.
Demographic information, blood pressure, LDL-cholesterol, and medications were obtained on 72,351 hypertensive patients from 262 primary care providers at 69 sites in the Southeast. Analysis focused on a dyslipidemic hypertensive subset.
Among 72,351 hypertensives, 38,116 were dyslipidemic. Fifty-two percent of patients did not have a cholesterol measurement documented in the past year. Women and patients <40 years old were less likely to have an annual cholesterol measurement than men and older, same-race counterparts (P < or = .001). Thirty-five percent of all hypertensive dyslipidemic patients had not been prescribed any anti-lipidemic medication, whereas 15% were on a statin and another anti-lipidemic. Women received fewer statin prescriptions than men (47.7% vs 65.1%, P < or = .0001). Fewer African Americans (AA) than Caucasians (C) reached LDL levels of <100 or <130 mg/dL (P < or = .0001). Among C and AA patients, those <40 years old were less likely than older, same-race counterparts to have reached LDL < 100 or <130 mg/dL (p < or = 001). Younger patients had fewer annual cholesterol measurements and were less likely to receive antilipidemic medication and to have LDL controlled than older, same-race counter-parts in each ethnic group (P < or = .0001).
Demographic characteristics of hypertensive patients, especially younger age group, are associated with significant differences in diagnostic testing, treatment, and control of hyperlipidemia in primary care. This primary care information can be used to guide education and policy interventions to improve outcomes and reduce disparities.
高血压患者合并血脂异常管理中的人口统计学差异可能导致健康差距。
评估初级保健中血脂异常高血压患者血脂控制率和治疗模式的人口统计学差异。
收集了来自东南部69个地点262名初级保健提供者的72351名高血压患者的人口统计学信息、血压、低密度脂蛋白胆固醇和用药情况。分析集中在血脂异常高血压亚组。
在72351名高血压患者中,38116名血脂异常。52%的患者在过去一年中没有胆固醇测量记录。女性和年龄小于40岁的患者比男性和年龄较大的同种族患者进行年度胆固醇测量的可能性更小(P≤0.001)。所有高血压血脂异常患者中,35%未开具任何抗血脂药物,而15%服用他汀类药物和另一种抗血脂药物。女性接受他汀类药物处方的比例低于男性(47.7%对65.1%,P≤0.0001)。达到低密度脂蛋白水平<100或<130mg/dL的非裔美国人(AA)比白人(C)少(P≤0.0001)。在C和AA患者中,年龄小于40岁的患者比年龄较大的同种族患者达到低密度脂蛋白<100或<130mg/dL的可能性更小(P≤0.001)。与各民族中年龄较大的同种族患者相比,年轻患者的年度胆固醇测量次数更少,接受抗血脂药物治疗的可能性更小,低密度脂蛋白得到控制的可能性也更小(P≤0.0001)。
高血压患者的人口统计学特征,尤其是年轻年龄组,与初级保健中高脂血症的诊断检测、治疗和控制存在显著差异有关。这些初级保健信息可用于指导教育和政策干预,以改善治疗效果并减少差距。